ADAMTS-13 assays in thrombotic thrombocytopenic purpura

被引:82
|
作者
Peyvandi, F. [1 ,2 ]
Palla, R. [1 ]
Lotta, L. A. [1 ]
Mackie, I. [2 ]
Scully, M. A. [2 ]
Machin, S. J. [2 ]
机构
[1] Univ Milan, Dept Med & Med Special,Luigi Villa Fdn, Angelo Bianchi Bonomi Hemophilia & Thrombosis Ctr, Fdn IRCCS Ca Granda,Osped Maggiore Policlin, Milan, Italy
[2] UCL, Dept Haematol, Haemostasis Res Unit, London, England
关键词
ADAMTS-13; assays; clinical utility; standardization; VON-WILLEBRAND-FACTOR; FACTOR-CLEAVING PROTEASE; HEMOLYTIC-UREMIC SYNDROME; ANTI-ADAMTS13; ANTIBODIES; FRETS-VWF73; ASSAY; ENZYME-IMMUNOASSAY; PROGNOSTIC VALUE; PLASMA-EXCHANGE; IGG ANTIBODIES; MICROANGIOPATHIES;
D O I
10.1111/j.1538-7836.2010.03761.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
ADAMTS-13, the thirteenth member of the ADAMTS (A Disintegrin And Metalloprotease with Thrombo-Spondin 1 repeats) family, is the plasma metalloprotease responsible for regulating the multimeric structure of VWF. In congenital or acquired deficiency it is actively involved in the pathophysiology of thrombotic thrombocytopenic purpura (TTP), a rare but life threatening disease characterized by microangiopathic haemolytic anaemia and consumptive thrombocytopenia leading to disseminated microvascular thrombosis and variable signs and symptoms of organ ischemia and damage. In the last few years, a number of in house and commercial laboratory assays for ADAMTS-13 and its autoantibodies have been developed. The features and clinical utility of ADAMTS-13 assays are summarized in this review.
引用
收藏
页码:631 / 640
页数:10
相关论文
共 50 条
  • [1] Thrombotic Microangiopathies, Thrombotic Thrombocytopenic Purpura, and ADAMTS-13
    Chapman, Kent
    Seldon, Michael
    Richards, Ross
    SEMINARS IN THROMBOSIS AND HEMOSTASIS, 2012, 38 (01): : 47 - 54
  • [2] Deficiency of ADAMTS-13 in thrombotic and thrombocytopenic purpura
    Tsai, HM
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2003, 1 (09) : 2038 - 2040
  • [3] Thrombotic thrombocytopenic purpura: is there more than ADAMTS-13?
    Thachil, J.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2007, 5 (03) : 634 - 635
  • [4] Is ADAMTS-13 deficiency specific for thrombotic thrombocytopenic purpura? No
    Remuzzi, G
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2003, 1 (04) : 632 - 634
  • [5] Targeted ADAMTS-13 replacement therapy for thrombotic thrombocytopenic purpura
    Moroniti, Jonathan J.
    Vrbensky, John R.
    Nazy, Ishac
    Arnold, Donald M.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2024, 22 (04) : 896 - 904
  • [6] Low ADAMTS-13 in plavix induced thrombotic thrombocytopenic purpura
    Cao, Long Bao
    Jones, Christopher
    Movahed, Assad
    WORLD JOURNAL OF CLINICAL CASES, 2013, 1 (01) : 31 - 33
  • [7] Low ADAMTS-13 in plavix induced thrombotic thrombocytopenic purpura
    Long Bao Cao
    Christopher Jones
    Assad Movahed
    World Journal of Clinical Cases, 2013, (01) : 31 - 33
  • [8] Von Willebrand factor, ADAMTS-13, and thrombotic thrombocytopenic purpura
    Moake, JL
    SEMINARS IN HEMATOLOGY, 2004, 41 (01) : 4 - 14
  • [9] Von Willebrand Factor, ADAMTS-13, and Thrombotic Thrombocytopenic Purpura
    Zhou, Zhou
    Nguyen, Trung C.
    Guchhait, Prasenjit
    Dong, Jing-fei
    SEMINARS IN THROMBOSIS AND HEMOSTASIS, 2010, 36 (01): : 71 - 81
  • [10] Thrombotic, thrombocytopenic purpura (ADAMTS-13 deficiency): a rare neonatal presentation
    Sutton, Rachael
    Will, Andrew
    Kuruvilla, Minju
    Victor, Suresh
    CASE REPORTS IN PERINATAL MEDICINE, 2015, 4 (01): : 73 - 75